Skip to Content

Flutiform Approval Status

FDA Approved: No
Brand name: Flutiform
Generic name: fluticasone and formoterol
Dosage form: Inhalation Aerosol
Company: Vectura Group plc
Treatment for: Asthma

Flutiform (fluticasone and formoterol) metered dose inhaler is a corticosteroid and long-acting beta-agonist fixed-dose combination in development for the treatment of asthma.

Development Status and FDA Approval Process for Flutiform

Jun 10, 2009SkyePharma Inc. Says FDA May Need More Flutiform Data
May 22, 2009Skyepharma plc: Flutiform NDA Accepted for Review
Aug  6, 2007SkyePharma PLC - Flutiform Progress Update

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.